Driehaus Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Driehaus Capital Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,695	Closed	-$228K	–	691
2015 Q4	$228K	Buy	+3,695	New	+$260K	0.01%	496
2015 Q2	–	Sell	-17,285	Closed	-$997K	–	639
2015 Q1	$997K	Buy	+17,285	New	+$1.16M	0.03%	409

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Driehaus Capital Management's KITE Position: Q1 2016 in Review

Driehaus Capital Management sold out of Kite Pharma, Inc. (KITE) in Q1 2016, closing a stake of 3,695 shares — an estimated $228K sold.

Driehaus Capital Management first reported a position in KITE in Q1 2015 and held it in 2 quarters. The position peaked at $997K in Q1 2015. 171 funds tracked by Wall St. Rank hold KITE as of Q1 2016.

Driehaus Capital Management reported no remaining Kite Pharma, Inc. position as of Q1 2016 after selling out during the quarter.
Driehaus Capital Management sold 3,695 Kite Pharma, Inc. shares in Q1 2016, an estimated $228K.
Driehaus Capital Management first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 2 quarters.
Driehaus Capital Management's Kite Pharma, Inc. position peaked at $997K in Q1 2015.
171 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2016.

Based on Driehaus Capital Management's 13F filing for Q1 2016, filed 13 May 2016.